Riken Vitamin Co., Ltd.

TSE:4526 Stock Report

Market Cap: JP¥74.6b

Riken Vitamin Management

Management criteria checks 2/4

Riken Vitamin's CEO is Kazuhiko Yamaki, appointed in Jun 2016, has a tenure of 8.92 years. directly owns 0.05% of the company’s shares, worth ¥37.45M. The average tenure of the management team and the board of directors is 4.3 years and 3.9 years respectively.

Key information

Kazuhiko Yamaki

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.9yrs
CEO ownership0.05%
Management average tenure4.3yrs
Board average tenure3.9yrs

Recent management updates

Recent updates

Riken Vitamin's (TSE:4526) Solid Earnings May Rest On Weak Foundations

May 22
Riken Vitamin's (TSE:4526) Solid Earnings May Rest On Weak Foundations

Riken Vitamin's (TSE:4526) Earnings Are Of Questionable Quality

Nov 21
Riken Vitamin's (TSE:4526) Earnings Are Of Questionable Quality

Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Aug 28
Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Riken Vitamin (TSE:4526) Has Announced A Dividend Of ¥40.50

Aug 13
Riken Vitamin (TSE:4526) Has Announced A Dividend Of ¥40.50

Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Jul 26
Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Riken Vitamin's (TSE:4526) Dividend Will Be ¥40.50

Jul 11
Riken Vitamin's (TSE:4526) Dividend Will Be ¥40.50

Riken Vitamin's (TSE:4526) Promising Earnings May Rest On Soft Foundations

May 21
Riken Vitamin's (TSE:4526) Promising Earnings May Rest On Soft Foundations

Riken Vitamin (TSE:4526) Has Announced That It Will Be Increasing Its Dividend To ¥44.50

Mar 15
Riken Vitamin (TSE:4526) Has Announced That It Will Be Increasing Its Dividend To ¥44.50

Riken Vitamin (TSE:4526) Is Increasing Its Dividend To ¥44.50

Mar 01
Riken Vitamin (TSE:4526) Is Increasing Its Dividend To ¥44.50

CEO

Kazuhiko Yamaki (65 yo)

8.9yrs
Tenure

Mr. Kazuhiko Yamaki serves as the President at Riken Vitamin Co., Ltd. since June 2016 and served as its Executive Officer since July 2006. Mr. Yamaki served as its Managing Director at Riken Vitamin Co.,...

Leadership Team

NamePositionTenureCompensationOwnership
Kazuhiko Yamaki
President & Representative Director8.9yrsno data0.050%
¥ 37.5m
Hiroyuki Hashino
Accounting Managerno datano datano data
Nobuo Dotsu
MD of Administrative1.9yrsno data0.013%
¥ 10.0m
Toshiyuki Tanaka
Executive Officer & GM of Human Resources Departmentno datano datano data
Takahisa Nakano
Senior MD & Representative Director2.9yrsno data0.033%
¥ 25.0m
Atsushi Mochizuki
MD of International Business Department & Director5.9yrsno data0.013%
¥ 10.0m
Takumi Aoki
Managing Executive Officer3.3yrsno datano data
Shinichi Koyama
Managing Executive Officerno datano datano data
Masaaki Nakano
Managing Executive Officer & GM of Food Sales Division5.3yrsno datano data
Yoshiya Inoue
Chief of PR & IR Office - Corporate Planning Departmentno datano datano data
Takahiro Tomitori
Head of Corporate Strategy & Directorno datano data0.0034%
¥ 2.5m
4.3yrs
Average Tenure
64yo
Average Age

Experienced Management: 4526's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kazuhiko Yamaki
President & Representative Director14.9yrsno data0.050%
¥ 37.5m
Nobuo Dotsu
MD of Administrative2.9yrsno data0.013%
¥ 10.0m
Takahisa Nakano
Senior MD & Representative Director12.9yrsno data0.033%
¥ 25.0m
Atsushi Mochizuki
MD of International Business Department & Director2.9yrsno data0.013%
¥ 10.0m
Takahiro Tomitori
Head of Corporate Strategy & Director3.9yrsno data0.0034%
¥ 2.5m
Eiichi Katou
Director3.9yrsno data0.020%
¥ 15.0m
Satoshi Fujinaga
Independent Outside Director7.9yrsno data0.013%
¥ 10.0m
Hisayoshi Sueyoshi
Independent External Director7.9yrsno data0.010%
¥ 7.5m
Shinichi Hirano
Independent Outside Director3.9yrsno data0.0034%
¥ 2.5m
Wataru Sueyoshi
Independent Outside Director3.9yrsno datano data
Ayumi Ujihara
Independent Outside Director1.9yrsno datano data
3.9yrs
Average Tenure
65yo
Average Age

Experienced Board: 4526's board of directors are considered experienced (3.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/23 09:37
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Riken Vitamin Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCompany Forecast
Yumiko KaiIchiyoshi Research Institute Inc.